Restoring digestive motor function to allow better and safer nutrition
Millions of people suffer from reduced or lack of motor function of their digestive system, presented as impaired esophageal motion and delayed gastric emptying, leading to malnutrition and higher risk of infection.
This phenomenon is very common in critically ill patients, as well as neurological, surgical, geriatric, neonatal and others, impairing their general well being and quality of life, while being associated with significant increase in direct medical cost.
E-Motion Medical’s mission is to restore digestive motor function to these patients, reduce infectious complications, and improve survival and physical function.
“Let food be thy medicine
and medicine be thy food”
Our simple, yet revolutionary, technology is designed to shift the paradigm of digestive care, by promoting motor function of the digestive system, improving patient outcomes and lowering the financial burden for healthcare providers.
The E-Motion System™ delivers unique patterns of stimulation to the esophagus, thereby generating contractions, which restore natural function to the digestive system and promote motility throughout the gastrointestinal tract.
The stimulation is applied to the esophagus using our proprietary E-Motion Tube™, which can also double as a feeding tube, and is easily placed in the same manner.
Our technology has been successfully applied to 15 healthy volunteers and more than 120 ICU patients in over a dozen hospitals around the world, in several clinical trials.
The clinical trials demonstrate the safety of our technology, and the effect of the stimulation on gastric emptying, reflux and aspiration, and recuperation time for ICU patients, while minimizing workload for the medical staff.
Investigating physicians who participated in our trials expressed great enthusiasm and some even reported that enrolled patients tended towards faster and better healing than anticipated, as well as fewer complications and infections than can be expected for patients in their condition.
E-Motion Medical Ltd was founded in 2011 by a pioneering multidisciplinary team with extensive experience in medicine, science, management and business.
Mr. Gross is CEO of E-Motion Medical since its inception and an accomplished executive with over 15 years of experience in medical devices, rehabilitation, and aerospace.
Previously, Mr. Gross co-founded an assistive tech company (softwheel.technology), founded and headed an innovative product line of airborne systems at Rafael, and served as Captain in the Air Force and as faculty member at the Technion – Israel Institute of Technology.
Mr. Gross received his MSc in Aerospace Engineering from the Technion, and his MBA in marketing and finance from the Herzliya Interdisciplinary Center.
Dr. Tal is an interventional radiologist with expertise in minimally invasive procedures, serving as Head of Interventional Radiology at Assuta Medical Center and Associate Professor at the Yale University School of Medicine.
After graduating from Hadassah Medical School in Jerusalem, Dr. Tal went on to complete his residence at MCP Hahnemann University in Philadelphia and Yale University, and to receive his MBA from the Yale Business School.
Dr. Tal invented several medical devices that are on the market in the US today, and co-founded several medical device companies, such as Accurate Medical Therapeutics, acquired by Guerbet Group.
Dr. Berra is a specialist in anesthesiology and critical care, and has special interest in respiratory care, transfusion medicine and complications in ICU, which he researched for several years at the National Institute of Health.
Dr. Berra serves as attending physician at the Surgical ICU at Massachusetts General Hospital and as Assistant Professor at the Harvard Medical School.
Dr. Berra received his MD from the University of Milan, and completed his residency and fellowship at Massachusetts General Hospital.
Dr. Sessler is a specialist in pediatric and anesthesia, and currently serves as Professor and Chair of Outcomes Research at the Cleveland Clinic and the Outcomes Research Consortium (www.OR.org), which coordinate more than a hundred simultaneous clinical studies.
Dr. Sessler attended Columbia University, and completed pediatric and anesthesia residencies at UCLA.
Dr. Sessler has published a book and over 600 full papers, have been cited more than 25,000 times, and raised more than $35 million in grant funding.
Dr. Talmor is the Lowenstein Professor of Anaesthesia at Harvard Medical School and Chair of
the Department of Anesthesia, Critical Care and Pain Medicine at Beth Israel Deaconess
Medical Center in Boston.
Dr. Talmor attends clinically both in the operating room and the surgical ICU. His research
group focuses on the early identification, prevention and treatment of critical illness.
Dr. Talmor received his MD and from the Ben Gurion University, and completed his
fellowship at Beth Israel Deaconess Medical Center.
Having served as Director of FDA’s Office of Device Evaluation and as SVP and Chief Regulatory Officer at Medtronic and CR Bard, Dr. Alpert’s influence on current and future of the US healthcare system is instrumental.
Dr. Alpert is a microbiologist and pediatrician with a specialty in infectious diseases with vast experience in clinical and regulatory affairs.
Dr. Bardan is a specialist in internal medicine and gastroenterology, and has special interest in neurogastroenterology and esophageal motility.
Currently serving as deputy director of the Gastroenterology and Hepatology unit at Sheba Medical Center, Dr. Bardan is also a lecturer at his alma mater, the Sackler School of Medicine at Tel- Aviv University.
Dr. Bardan formerly served as research Fellow at the Medical School of Wisconsin in Milwaukee.
Dr. Rosenheck is a specialist in cardiology and electrophysiology, and has special interest in pacemakers and arrhythmias, which he studied for several years as research fellow at the Hebrew University in Jerusalem.
Dr. Rosenheck served as director of the Arryhtmia Unit, at the Cardiology Deprtment at Haddasah Medical Center, and is currently attending at the Meir and Assuta Medical Centers.
Dr. Rosenheck received his MD from Hadassah Medical School, and completed his residency and fellowship at Soroka and Hadassah Hospitals, and at University of Michigan Hospital at Ann Arbor.
Mr. Halperin is CEO of EarlySense Ltd (earlysense.com) since its incorporation and a veteran high-tech executive, previously serving as CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and VP of Business Development at Lenslet.
Mr. Halperin received his MSc in Applied Physics from Tel Aviv University and his MBA from MIT Sloan Business School.
David spent 25 years in the medical technology industry, directing strategic and business development, and leading M&A, licensing, and distribution deals for companies such as Medtronic, Covidien, Hologic, Boston Scientific, and more.
David received his BA from Clark University, and his MA and MBA from the Thunderbird School of Global Management.
E-Motion Medical LTD
10 HaNehoshet St.
Tel Aviv 69710